GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societal CDMO Inc (FRA:RAH) » Definitions » ROE % Adjusted to Book Value

Societal CDMO (FRA:RAH) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Societal CDMO ROE % Adjusted to Book Value?

Societal CDMO's ROE % for the quarter that ended in Dec. 2023 was -5.32%. Societal CDMO's PB Ratio for the quarter that ended in Dec. 2023 was N/A. Societal CDMO's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.


Societal CDMO ROE % Adjusted to Book Value Historical Data

The historical data trend for Societal CDMO's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societal CDMO ROE % Adjusted to Book Value Chart

Societal CDMO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -15.71 -

Societal CDMO Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.49 -11.57 -8.15 -10.85 -

Competitive Comparison of Societal CDMO's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Societal CDMO's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societal CDMO's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societal CDMO's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Societal CDMO's ROE % Adjusted to Book Value falls into.



Societal CDMO ROE % Adjusted to Book Value Calculation

Societal CDMO's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-22.07% / N/A
=N/A

Societal CDMO's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-5.32% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Societal CDMO ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Societal CDMO's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Societal CDMO (FRA:RAH) Business Description

Traded in Other Exchanges
Address
1 E. Uwchlan Avenue, Suite 112, Exton, PA, USA, 19341
Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. The company also provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services to the global pharmaceutical market.

Societal CDMO (FRA:RAH) Headlines

No Headlines